|
|
在研机构- |
|
在研适应症- |
|
最高研发阶段终止 |
首次获批国家/地区- |
首次获批日期- |
An Open-label, Multicentric, Non-comparative, observational, Phase-IV Clinical Trial toEvaluate Safety, Tolerability and Efficacy of Oral Tablets of Fixed-dose Combination ofCamylofin Dihydrochloride 50 mg and Paracetamol IP 325 mg in the treatment of PrimaryDysmenorrhoea, Colicâ??
The evaluation of TruScreen Ultra Optical device vs Pap smear for Cervical Screening in General Screening Population: a comparative study
100 项与 Khandelwal Laboratories Pvt Ltd. 相关的临床结果
0 项与 Khandelwal Laboratories Pvt Ltd. 相关的专利(医药)
100 项与 Khandelwal Laboratories Pvt Ltd. 相关的药物交易
100 项与 Khandelwal Laboratories Pvt Ltd. 相关的转化医学